TPCHRF - Round 6 - Pre-clinical assessment of poly-arginine R18 peptide as neuroprotective agent for perinatal hypoxic-ischaemic encephalopathy (HIE)

    Project Details

    StatusFinished
    Effective start/end date1/07/1830/06/20

    Funding

    • Government of Western Australia, Department of Health: A$60,594.00
    • Government of Western Australia, Department of Health: A$27,201.00
    • Government of Western Australia, Department of Health: A$87,105.00